|
John D. Mendlein PhD JD has served as a director since December 2004. Dr. Mendlein was a member of ACLARA Biosciences Inc.'s board of directors from April 2003 to December 2004. Dr. Mendlein is Chief Executive Officer of Compound Therapeutics. Dr. Mendlein is Chairman of Affinium Pharmaceuticals Inc. a drug discovery company and also served as Chief Executive Officer from November 2000 to June 2005. Prior to joining Affinium Dr. Mendlein served as Chief Knowledge Officer General Counsel and Senior Vice President Intellectual Property of Aurora Biosciences Corporation from 1996 until 2000. Dr. Mendlein holds a PhD in physiology and biophysics from the University of California Los Angeles and a JD degree from the University of California Hastings College of Law. | 